We are live on ! Find out more
PAG

Private Advisor Group Portfolio holdings

AUM $21.8B
1-Year Est. Return 28.57%
This Fund
S&P 500
This Quarter Est. Return
+6.89%
1 Year Est. Return
+28.57%
3 Year Est. Return
+77.38%
5 Year Est. Return
+84.64%
10 Year Est. Return
+284.63%
AUM
$11.4B
AUM Growth
+$967M
Cap. Flow
+$306M
Cap. Flow %
2.67%
Top 10 Hldgs %
17.58%
Holding
2,072
New
184
Increased
1,131
Reduced
580
Closed
89
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFD
1851
Flaherty & Crumrine Preferred and Income Fund
PFD
$142M
$167K ﹤0.01%
10,009
-2,823
-22% -$49.6K
FNB icon
1852
FNB Corp
FNB
$6.5B
$165K ﹤0.01%
13,405
+652
+5% +$8.47K
WIA
1853
Western Asset Inflation-Linked Income Fund
WIA
$182M
$163K ﹤0.01%
11,670
TEVA icon
1854
Teva Pharmaceutical Industries Limited
TEVA
$45.8B
$162K ﹤0.01%
16,363
+585
+4% +$6.19K
BCS icon
1855
Barclays
BCS
$85.2B
$161K ﹤0.01%
16,724
-124
-0.7% -$1.27K
DB icon
1856
Deutsche Bank
DB
$72.7B
$161K ﹤0.01%
12,330
-2,000
-14% -$27.1K
JCO
1857
DELISTED
Nuveen Credit Opportunities 2022 Target Term Fund
JCO
$161K ﹤0.01%
19,375
+2,000
+12% +$17K
KOPN icon
1858
Kopin
KOPN
$807M
$160K ﹤0.01%
19,608
-2,267
-10% -$18.8K
FAT
1859
DELISTED
FAT Brands
FAT
$159K ﹤0.01%
19,605
-129
-0.7% -$748
MCN
1860
Madison Covered Call & Equity Strategy Fund
MCN
$115M
$159K ﹤0.01%
19,700
+7,500
+61% +$60.2K
HFRO
1861
Highland Opportunities and Income Fund
HFRO
$388M
$157K ﹤0.01%
14,366
+24
+0.2% +$271
ORMP icon
1862
Oramed Pharmaceuticals
ORMP
$192M
$154K ﹤0.01%
+11,511
New +$132K
AMCR icon
1863
Amcor
AMCR
$19.6B
$153K ﹤0.01%
+2,662
New +$158K
PFO
1864
Flaherty & Crumrine Preferred and Income Opportunity Fund
PFO
$116M
$153K ﹤0.01%
11,428
-612
-5% -$8.13K
IGR
1865
CBRE Global Real Estate Income Fund
IGR
$625M
$152K ﹤0.01%
5,768
+1,608
+39% +$40.5K
KMF
1866
DELISTED
Kayne Anderson NextGen Energy & Infrastructure, Inc.
KMF
$152K ﹤0.01%
20,150
-500
-2% -$3.52K
BRMK
1867
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$152K ﹤0.01%
14,365
PGEN icon
1868
Precigen
PGEN
$2.51B
$149K ﹤0.01%
22,855
-4,900
-18% -$34.2K
SCYX icon
1869
SCYNEXIS
SCYX
$43.7M
$147K ﹤0.01%
2,500
AIV
1870
Aimco
AIV
$333M
$144K ﹤0.01%
21,486
-133
-0.6% -$915
CRMD icon
1871
CorMedix
CRMD
$605M
$143K ﹤0.01%
20,879
PCG icon
1872
PG&E
PCG
$29B
$142K ﹤0.01%
+13,981
New +$150K
DFTX
1873
Definium Therapeutics
DFTX
$4.95B
$141K ﹤0.01%
+2,746
New +$144K
OIS icon
1874
Oil States International
OIS
$519M
$140K ﹤0.01%
17,805
+5,907
+50% +$39.5K
MFG icon
1875
Mizuho Financial
MFG
$135B
$138K ﹤0.01%
48,370
-4,236
-8% -$12.6K

Similar funds

Private Advisor Group's Q2 2021 Portfolio in Review

As of Q2 2021, Private Advisor Group held 2,072 positions worth $11.4B, up 9.2% from $10.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Private Advisor Group's Q2 2021 filing shows 184 new, 1,131 increased, 580 reduced and 89 closed positions. Its largest new stake was Dimensional US Core Equity 2 ETF: 1,222,060 shares worth $33M. The largest sale was Vanguard Morningstar Large-Cap ETF, an estimated $42.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, up from 65% a quarter earlier, followed by Technology and Healthcare.

  • Private Advisor Group's largest Q2 2021 buy was Dimensional US Core Equity 2 ETF: 1,222,060 shares worth $33M.
  • Private Advisor Group added most to State Street SPDR Portfolio S&P 500 ETF in Q2 2021, an estimated $52.9M increase.
  • Private Advisor Group's biggest Q2 2021 reduction was Vanguard Morningstar Large-Cap ETF, cutting an estimated $42.3M.
  • Private Advisor Group fully exited FS KKR Capital Corp. II in Q2 2021, selling an estimated $3.82M.
  • Private Advisor Group's ten largest holdings make up 18% of its $11.4B portfolio in Q2 2021.
  • Private Advisor Group opened 184 new positions and closed 89 in Q2 2021.
  • Private Advisor Group's portfolio value rose 9.2% quarter-over-quarter to $11.4B.

Based on Private Advisor Group's 13F filing for Q2 2021, filed 12 Aug 2021.